✦ LIBER ✦

Targeted therapy for NSCLC with driver mutations

✍ Scribed by Minuti, Gabriele; D'Incecco, Armida; Cappuzzo, Federico

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Targeted therapy for NSCLC: ALK inhibiti

✍ Pearson, R.; Kolesar, J. M. 📂 Article 📅 2011 🏛 SAGE Publications 🌐 English ⚖ 135 KB

Targeted therapy with erlotinib prolongs

✍ James R. Rigas; Konstantin H. Dragnev 📂 Article 📅 2005 🏛 Frontline Medical Communications, Inc. 🌐 English ⚖ 171 KB

42IN ADVANCED NSCLC: MAINTENANCE WITH TA

✍ Gridelli, C. 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 71 KB

Targeted therapies: Tyrosine-kinase inhi

✍ Saijo, Nagahiro 📂 Article 📅 2010 🏛 Nature Publishing Group 🌐 English ⚖ 152 KB

NSCLC: novel targeted therapies offer ho

✍ Marianne Nicolson; Asa Dahle-Smith 📂 Article 📅 2011 🏛 Wiley (John Wiley & Sons) ⚖ 153 KB

MTOR Mutations in the Crosshairs of Targ

✍ Rejto, P. A.; Abraham, R. T. 📂 Article 📅 2014 🏛 American Association for Cancer Research 🌐 English ⚖ 436 KB